Study Questions Use of Branded Inhalers for COPD

Researchers said their analysis found that a generic product approved in 2019 was equally effective as the more expensive original.

Related Keywords

Alabama ,United States ,Boston ,Massachusetts ,William Feldman ,Surya Bhatt ,Advair Diskus ,Wixela Inhub ,Drug Administration ,Physiology Lab ,Glaxosmithkline ,Harvard Medical School ,Commonwealth Fund ,National Heart ,University Of Alabama Birmingham ,Blood Institute ,Alosa Health ,Internal Medicine ,Different Inhalers ,Pulmonary Function ,Exercise Physiology Lab ,Arnold Ventures ,Chronic Obstructive Pulmonary Disease Copd ,Chronic Obstructive Pulmonary Disease ,Copd ,Chronic Obstructive Lung Disease ,Drug Costs ,Generics ,Generic Drug ,Eneric Medication ,Inhaler ,Asthma ,Sthmatic ,Practice Management ,Physical Medicine And Rehabilitation ,Hysiatry ,Cancer ,Alignant Neoplasia ,Arcinoma ,Exercise Physiology ,Hospitals ,Insurance ,Leukemia ,Lung ,Severe Chronic Obstructive Pulmonar ,